This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...